Lynx1 Capital Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.3M | Buy |
5,404,674
+112,745
| +2% | +$1.28M | 17.72% | 3 |
|
|
2025
Q1 | $35.2M | Buy |
5,291,929
+104,738
| +2% | +$697K | 12.6% | 4 |
|
|
2024
Q4 | $57.2M | Hold |
5,187,191
| – | – | 21.45% | 2 |
|
|
2024
Q3 | $63.8M | Buy |
5,187,191
+2,000
| +0% | +$24.6K | 22.59% | 2 |
|
|
2024
Q2 | $70.1M | Buy |
5,185,191
+1,488,371
| +40% | +$20.1M | 25.27% | 2 |
|
|
2024
Q1 | $49.9M | Buy |
3,696,820
+739,902
| +25% | +$9.99M | 12.85% | 3 |
|
|
2023
Q4 | $15.6M | Buy |
2,956,918
+1,246,764
| +73% | +$6.56M | 6.12% | 6 |
|
|
2023
Q3 | $6.74M | Buy |
+1,710,154
| New | +$6.74M | 4.46% | 7 |
|